BERLIN (AP) — Germany, France, Italy and Spain have become the latest countries to suspend use of AstraZeneca’s COVID-19 vaccine over reports of dangerous blood clots in some recipients, though the company and European regulators have said there is no evidence the shot is to blame. AstraZeneca’s formula is just one of three vaccines in use on the continent. But the move amounts to another setback for the European Union’s vaccine rollout, which has been plagued by supply shortages and other hurdles. It is lagging well behind the campaigns in Britain and the U.S.
Major European nations suspend use of AstraZeneca vaccine
